Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Lucero

Dentist, Pediatric Dentistry Aurora, CO Doctor of Dentistry

NPI 1306158886 CMS profile 882991

14991 E Hampden Ave Ste 370, Ste 140, Aurora, CO 80014

Open in the dashboard

General payments

$137,115

218 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Lucero of Aurora, CO is reported in the CMS Open Payments database as having received $137,115 across 218 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, Pediatric Dentistry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $37,560 40
2024 General $23,711 35
2023 General $30,271 55
2022 General $29,105 56
2021 General $10,913 16
2020 General $1,511 5
2019 General $4,045 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Lucero
  • Dentist, Pediatric Dentistry median
  • Middle half of Dentist, Pediatric Dentistry
  • National median

In program year 2025, general payments to Matthew Lucero were reported at $37,560. Among 2,761 Dentist, Pediatric Dentistry profiles paid that year, the median was $43 and the middle half received between $19 and $117.

Show as a table
Year Matthew Lucero Dentist, Pediatric Dentistry median Middle half National median
2019 $4,045 $40 $17–$119 $163
2020 $1,511 $43 $17–$89 $114
2021 $10,913 $38 $17–$115 $132
2022 $29,105 $43 $17–$130 $149
2023 $30,271 $44 $19–$137 $160
2024 $23,711 $43 $19–$117 $164
2025 $37,560 $43 $19–$117 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuSmile, Ltd. $136,971 216 payments
  2. Galderma Laboratories, L.P. $119 1 payment
  3. b2d Marketing $26 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $62,750 32 payments
  2. Travel and Lodging $42,065 61 payments
  3. Consulting Fee $19,550 11 payments
  4. Food and Beverage $7,430 101 payments
  5. Entertainment $3,782 4 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $531 2 payments
  7. Gift $507 6 payments
  8. Education $500 1 payment
Products named General payments · program years 2019–2025
  1. ZR CROWNS $84,906 101 payments
  2. BIOFLX $77,013 76 payments
  3. SIGNATURE CROWNS $68,237 65 payments
  4. NeoPUTTY $49,681 45 payments
  5. SSC $45,632 36 payments
  6. STAINLESS STEEL CROWNS $37,104 49 payments
  7. NEOMTA $33,598 48 payments
  8. ZR $29,789 18 payments
  9. SIGNATURE $29,789 18 payments
  10. SPACE MAINTAINERS $29,789 18 payments
  11. Other $66,980 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

218 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record